Christopher A. Seid

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

Wen‐Hsiang Chen, Lanying Du, Shivali Chag et al. · Human Vaccines & Immunotherapeutics · 2013 · 129 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Biology +17

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

Wen‐Hsiang Chen, Shivali Chag, Mohan‐Vivekanandan Poongavanam et al. · Journal of Pharmaceutical Sciences · 2017 · 115 citations · Full text

Life Sciences, Biotechnology, Infectious Diseases +14

Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells

Catherine A. O’Brian, Dominic Fan, Nancy E. Ward et al. · FEBS Letters · 1989 · 86 citations · Full text

Medicine, Cancer Biology, Oncology +16

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen

Mun Peak Nyon, Lanying Du, Chien‐Te K. Tseng et al. · Vaccine · 2018 · 71 citations

Life Sciences, Infectious Diseases, Microbiology +13

Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice

Viridiana Martínez-Campos, Pedro Pablo Martínez-Vega, María Jesús Ramírez-Sierra et al. · Vaccine · 2015 · 61 citations

Veterinary Medicine, Immunology, Infectious Diseases +16